5 Results for "

IgG1 Fc silencing

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "IgG1 Fc silencing" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P99033
CAS No.: 1905409-39-3
Synonyms: BTCT-4465A; RG-7828; RO7030816
Target:  

CD20 CD3

Research Areas:  

Cancer

Mosunetuzumab (BTCT-4465A) is a full-length, fully humanized immunoglobulin G1 (IgG1) T-cell-dependent bispecific (TDB) antibody targeting CD20 (B cells) and CD3 (T cells). Mosunetuzumab redirects T cells to engage and eliminate malignant B cells and can be used for the research of relapsed or refractory (R/R) B-cell non-Hodgkin lymphomas (B-NHLs). The Fc region of Mosunetuzumab incorporates a "knob-into-hole" structural modification and an N297G point mutation to achieve heterodimerization and eliminate Fc glycosylation, thereby effectively silencing antibody effector functions .
loading...
    loading...
Cat. No.: HY-P99807
CAS No.: 2093956-19-3
Synonyms: BCD-100

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Prolgolimab (BCD-100) is a human IgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing 'LALA' mutation. Prolgolimab can be used for the research of advanced melanoma .
loading...
    loading...
Cat. No.: HY-P991564
CAS No.: 3031170-61-0
Synonyms: IBI-343 antibody; HB37A6; TAK-921 Antibody

Target:  

ADC Antibodies Claudin

Research Areas:  

Cancer

Arcotatug (IBI-343 antibody) is a CLDN18.2 targeting humanized monoclonal antibody. Arcotatug can be used for synthesis of ADCs .
loading...
    loading...
Cat. No.: HY-P991940

Target:  

ADC Antibodies CCR

Research Areas:  

Cancer

JBH492 Antibody is a humanized, Fc-silenced anti-CCR7 IgG1 antibody. JBH492 Antibody can generate antibody drug conjugate (ADC) (JBH492) with a maytansinoid microtubule DM4 (HY-12454). JBH492 Antibody can be used for the study of lymphoma .
loading...
    loading...
Cat. No.: HY-P991922
AKIR001 is a high-affinity human IgG1 antibody targeting CD44v6. AKIR001 carries LALA-silencing mutations in its FcγR-binding domain to reduce FcγR and C1q interactions, minimizing tissue interactions and limiting CDC and ADCC risks. [ 177Lu] radiolabeled AKIR001, namely [ 177Lu]Lu-AKIR001, has anticancer activity against epidermoid carcinoma .
loading...
    loading...